NCT06089083 PROmOting Gynecologic Cancer Patients With Frailty to Achieve Functional Recovery
| NCT ID | NCT06089083 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of California, San Francisco |
| Condition | Malignant Female Reproductive System Neoplasm |
| Study Type | OBSERVATIONAL |
| Enrollment | 500 participants |
| Start Date | 2023-10-18 |
| Primary Completion | 2027-11-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 500 participants in total. It began in 2023-10-18 with a primary completion date of 2027-11-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study seeks to understand how frailty, a term that describes people who are more vulnerable stressors such as a new medical problem, affects the outcomes and quality of life in adult patients with gynecologic cancer.
Eligibility Criteria
Inclusion Criteria: * Age 18 years or greater * Undergoing evaluation for a newly diagnosed gynecologic malignancy * Ability of individual or legal guardian/representative to understand a written informed consent document, and the willingness to sign it Exclusion Criteria: * Contraindication to any study-related procedure or assessment * Does not speak a language for which the consent form and study materials are available
Contact & Investigator
Stephanie Cham, MD
PRINCIPAL INVESTIGATOR
University of California, San Francisco
Frequently Asked Questions
Who can join the NCT06089083 clinical trial?
This trial is open to female participants only, aged 18 Years or older, studying Malignant Female Reproductive System Neoplasm. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06089083 currently recruiting?
Yes, NCT06089083 is actively recruiting participants. Contact the research team at janet.titzler@ucsf.edu for enrollment information.
Where is the NCT06089083 trial being conducted?
This trial is being conducted at San Francisco, United States, Boston, United States.
Who is sponsoring the NCT06089083 clinical trial?
NCT06089083 is sponsored by University of California, San Francisco. The principal investigator is Stephanie Cham, MD at University of California, San Francisco. The trial plans to enroll 500 participants.